Moreover, deleterious SMARCA4 mutations can be found throughout various cancer entities, including small cell carcinoma of the ovary, hypercalcemic type (SCCOHT), non-small cell lung cancer (NSCLC), pancreatic cancer, hepatocellular carcinoma, head and neck cancer, and atypical/teratoid rhabdoid tumors (ATRT) [15, 23, 27, 52]. Here, SMARCA4 is linked to non-small cell lung carcinoma.